In the Lab

Biotech Jason Mast

STAT Plus: For unlucky mountaineers, tundra explorers, and the unhoused, a new drug could avert the ravages of frostbite

Health Elizabeth Cooney

Smoking impairs immune response, even after quitting, new study says

Health Elaine Chen

Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease

In the Lab Angus Chen and Jonathan Wosen

STAT Plus: A flurry of research misconduct cases has universities scrambling to protect themselves

Exclusive Angus Chen and Jonathan Wosen

STAT Plus: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit

In the Lab Andrew Joseph

STAT Plus: A gene therapy designed to heal skin wounds helped preserve a boy’s vision

In the Lab Isabella Cueto

Mystery of allergic memory gets closer to answer: a rare group of B cells

In the Lab Jonathan Wosen

Clues from mice could help explain why women face a higher risk of autoimmune disorders

Health Elaine Chen

STAT Plus: Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses

In the Lab Andrew Joseph

Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure

In the Lab Andrew Joseph

Two genomics powerhouses team up to expand infectious disease surveillance

In the Lab Angus Chen and Jonathan Wosen

Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data

In the Lab Megan Molteni

New tool for tracing blood cells’ ancestry might one day help predict disease risk

In the Lab Jonathan Wosen and Angus Chen

STAT Plus: Dana-Farber cancer researchers moving to retract one paper, correct others in broad investigation of manipulated data

Health tech Deborah Balthazar

STAT Plus: A new, non-invasive test could help predict the quality of embryo used for IVF

In the Lab Angus Chen

STAT Plus: Hair loss is one of the most hated chemotherapy side effects. A new biotech hopes to prevent it

In the Lab Jonathan Wosen

Allen Institute CEO Rui Costa on mapping the brain and paying early-career scientists decent salaries

In the Lab Jonathan Wosen

NIH panel calls for fewer, better-paid postdocs in bid to halt loss of scientists to industry

Biotech Jason Mast

STAT Plus: Could sickle cell someday be treated not with CRISPR, but with a pill?

In the Lab Angus Chen

STAT Plus: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study

In the Lab Annalisa Merelli

STAT Plus: New proposals for scientific misconduct investigations worry some research universities

Health tech Deborah Balthazar

STAT Plus: In pigs, researchers show ultrasound could be used for 3D printing inside the body

In the Lab Jason Mast

‘Last roll of the dice’ for a near-term HIV vaccine fails

In the Lab Megan Molteni

STAT Plus: Using AI, scientists create blood test that measures organ aging and predicts disease risk

Biotech Jason Mast

STAT Plus: How sickle cell became the first disease treated by CRISPR

In the Lab Andrew Joseph

With latest tranche, U.K. Biobank has genome sequences from 500,000 people available for research

In the Lab Deborah Balthazar

What’s behind the urge to scratch that itch? Harvard researchers have a theory

Special Report Jonathan Wosen

STAT Plus: Life scientists’ flight to biotech labs stalls important academic research

In the Lab Anika Nayak

One-quarter of Americans have little to no confidence in scientists to act in public’s best interests, per report